Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyu Wan

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 8, 2019
The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in MiceXiangde Zhao, Lei Ning, Ziang Xie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancerWenjie Shi, Xinyu Wan, Ye Wang, et al.
Cancer Research and Treatment|September 29, 2021
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary RelapseXinyu Wan, Xiaomin Yang, Fan Yang, et al.
Cancer Science|February 14, 2023
MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4Ruozhu Wang, Wendan Yu, Tianhua Zhu, et al.
Journal of Translational Medicine|March 23, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapyWenjie Li, Lixia Ding, Wenhua Shi, et al.
Cell Reports|May 3, 2019
Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 DegradationDijue Sun, Urszula Stopka-Farooqui, Sayka Barry, et al.
Haematologica|March 19, 2026
CD19/CD22-targeted CAR T cells in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantationLiu Yang, Xinyu Wan, Chengjuan Luo, et al.
Frontiers in Pediatrics|January 28, 2025
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center studyJing Yang, Jing Zhang, Xinyu Wan, et al.
Redox Biology|August 6, 2022
BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25APing Guo, Shijia Zu, Shilong Han, et al.
Haematologica|May 22, 2025
Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapyXinyu Wan, Tianyi Wang, Jing Yang, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 8, 2019
The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in MiceXiangde Zhao, Lei Ning, Ziang Xie, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancerWenjie Shi, Xinyu Wan, Ye Wang, et al.
Cancer Research and Treatment|September 29, 2021
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary RelapseXinyu Wan, Xiaomin Yang, Fan Yang, et al.
Cancer Science|February 14, 2023
MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4Ruozhu Wang, Wendan Yu, Tianhua Zhu, et al.
Journal of Translational Medicine|March 23, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapyWenjie Li, Lixia Ding, Wenhua Shi, et al.
Cell Reports|May 3, 2019
Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 DegradationDijue Sun, Urszula Stopka-Farooqui, Sayka Barry, et al.
Haematologica|March 19, 2026
CD19/CD22-targeted CAR T cells in autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantationLiu Yang, Xinyu Wan, Chengjuan Luo, et al.
Frontiers in Pediatrics|January 28, 2025
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center studyJing Yang, Jing Zhang, Xinyu Wan, et al.
Redox Biology|August 6, 2022
BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25APing Guo, Shijia Zu, Shilong Han, et al.
Haematologica|May 22, 2025
Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapyXinyu Wan, Tianyi Wang, Jing Yang, et al.
Pageof 9